You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 26, 2025

Drug Price Trends for NDC 54482-0145


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 54482-0145

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
CARNITOR 1GM/10ML ORAL SOLUTION Leadiant Biosciences, Inc. 54482-0145-08 118ML 23.06 0.19542 2023-01-01 - 2026-08-31 FSS
CARNITOR 1GM/10ML ORAL SOLUTION Leadiant Biosciences, Inc. 54482-0145-08 118ML 22.88 0.19390 2024-01-01 - 2026-08-31 FSS
CARNITOR 1GM/10ML ORAL SOLUTION Leadiant Biosciences, Inc. 54482-0145-08 118ML 21.59 0.18297 2022-01-01 - 2026-08-31 FSS
CARNITOR 1GM/10ML ORAL SOLUTION Leadiant Biosciences, Inc. 54482-0145-08 118ML 20.48 0.17356 2021-09-01 - 2026-08-31 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 4 of 4 entries

Market Analysis and Price Projections for Carnitor (NDC: 54482-0145)

Overview of Carnitor

Carnitor, with the generic name Levocarnitine, is a prescription drug marketed by Leadiant Biosciences, Inc. It is available in various formulations, including oral solutions and tablets, and is used to treat carnitine deficiency and other conditions related to carnitine metabolism[5].

Current Pricing

As of the latest available data, the pricing for Carnitor (NDC: 54482-0145), which is the 1g/10mL oral solution, is as follows:

  • Price per Unit: Approximately $0.17356 per milliliter (ML)[1].
  • Total Price: For a package of 118 ML, the total price is around $20.48[1].

Historical Price Trends

Historical data indicates that the prices of Carnitor have been relatively stable over recent years. Here are some key points:

  • Price Stability: The price per unit for the 1g/10mL oral solution has remained consistent, with minor fluctuations. For example, the price per unit was $0.17356 as of December 2024, which is very close to the price in November 2024 ($0.17313)[1].
  • No Significant Increases: There have been no significant price increases reported for Carnitor in recent years, which suggests a stable market environment for this drug.

Market Analysis

The market for Carnitor is part of the broader biopharmaceutical market, which is experiencing significant growth driven by technological advancements and evolving regulatory frameworks.

Biopharma Market Growth

The biopharma market is projected to grow substantially, with a compound annual growth rate (CAGR) of 7.56% between 2024 and 2029. This growth is driven by innovations in clinical trial designs, precision medicine, and the integration of AI and ML technologies[3].

Competitive Landscape

While Carnitor is a specific product, the overall market for rare disease treatments and metabolic disorder medications is competitive. However, Carnitor holds a unique position due to its long marketing history and established patient base since its marketing start date in 1986[5].

Price Projections

Given the stable pricing trends and the absence of significant price increases, here are some projections for the future pricing of Carnitor:

Short-Term Projections

  • Stability: It is likely that the price of Carnitor will remain stable in the short term, reflecting the current market conditions and the lack of recent price hikes.
  • Minor Adjustments: Any price adjustments are expected to be minor and may reflect changes in production costs, regulatory fees, or market demand.

Long-Term Projections

  • Market Dynamics: The long-term pricing will be influenced by broader market dynamics, including the growth of the biopharma sector and any changes in the competitive landscape.
  • Generic Competition: Although Carnitor is a branded drug, the potential entry of generic versions could impact pricing. However, given its specific use case and patient base, the impact might be minimal.

Key Takeaways

  • Stable Pricing: Carnitor has shown stable pricing trends with no significant increases in recent years.
  • Market Growth: The biopharma market is growing, but this growth is more pronounced in other therapeutic areas rather than in the specific niche of carnitine deficiency treatments.
  • Competitive Position: Carnitor maintains a strong position in its market segment due to its long history and established patient base.

FAQs

Q: What is the current price per unit for Carnitor (NDC: 54482-0145)? A: The current price per unit for Carnitor (1g/10mL oral solution) is approximately $0.17356 per milliliter (ML)[1].

Q: Has there been any significant price increase for Carnitor in recent years? A: No, there have been no significant price increases reported for Carnitor in recent years[1].

Q: What is the projected market growth for the biopharma sector? A: The biopharma market is projected to grow at a CAGR of 7.56% between 2024 and 2029[3].

Q: Is Carnitor available in generic form? A: As of the latest data, Carnitor is a branded drug marketed by Leadiant Biosciences, Inc., and there is no widely available generic version[5].

Q: What factors could influence the long-term pricing of Carnitor? A: Long-term pricing could be influenced by market dynamics, regulatory changes, and the potential entry of generic versions, although the latter is less likely given its specific use case.

Sources

  1. DrugPatentWatch: Drug prices and trends for CARNITOR.
  2. Nevada Drug Transparency 2024 Drug Lists: Detailed list of National Drug Codes (NDCs) including varying drug packaging formulations.
  3. TFS CRO: 5 Predictions for the Biopharma and Biotech Industries in 2025.
  4. GlobalData: NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025.
  5. FDA.report: NDC 54482-145 Oral Solution Carnitor Drug Codes.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.